483
Billings Clinic Innovative FertilityBillings Clinic Innovative Fertility – FDA 483, Jul 14, 2023
Record Details
An FDA inspection of Billings Clinic Innovative Fertility identified a critical lapse in donor screening procedures. The firm failed to adequately screen reproductive tissue donors for communicable disease agents and diseases, including a specific instance where Zika Virus screening was omitted and another where no donor risk assessment was performed. This indicates a significant concern regarding the safety and eligibility of reproductive tissue donors.
View Company Profile
ID · 9eeb2385-66df-4cde-9777-f8bdfcd4eafa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.